Skip to content

Clinical trials

Terminated Phase 1 trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1 Status: Terminated Country / region: Japan Clear all

122 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20073
20081
20093
20102
20113
20121
20132
20144
20154
201610
20177
201810
201913
202017
202111
202212
20236
202410
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated122

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals26
Boehringer Ingelheim10
AbbVie9
Amgen9
Pfizer8
Eli Lilly and Company5
AstraZeneca4
Celgene4
Daiichi Sankyo Co., Ltd.4
Janssen Pharmaceutical K.K.4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms24
Carcinoma, Non-Small-Cell Lung21
Multiple Myeloma12
Lymphoma, Non-Hodgkin10
Leukemia, Myeloid, Acute9
Recurrence9
Carcinoma, Renal Cell7
Colorectal Neoplasms7
Melanoma7
Neoplasm Metastasis7

Trials

Showing 1 to 25 of 122. Each trial links to its page on Pharma Observatory.

22 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.